南京医药：第十届董事会第五次会议决议公告

Core Viewpoint - Nanjing Pharmaceutical announced the approval of several key proposals during its 10th Board of Directors' 5th meeting, including the establishment of a new investment company focused on medical device mergers and acquisitions [2] Group 1: Company Announcements - The company approved a proposal to participate in the establishment of Nanjing New Gongnan Pharmaceutical Medical Device Strong Chain M&A Equity Investment Limited Liability Company [2] - A proposal to change the purpose of share repurchase and to cancel certain shares was also approved [2] - The company approved a proposal to change its registered capital and amend certain provisions of its Articles of Association [2]